Psychemedics Profit Margin 2010-2024 | PMD

Current and historical gross margin, operating margin and net profit margin for Psychemedics (PMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Psychemedics net profit margin as of December 31, 2024 is -9.26%.
Psychemedics Annual Profit Margins
Psychemedics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.140B 18.86
Encompass Health (EHC) United States $11.843B 25.10
DaVita (DVA) United States $10.831B 15.23
Elanco Animal Health (ELAN) United States $7.470B 16.00
Chemed (CHE) United States $6.813B 21.41
Option Care Health (OPCH) United States $4.993B 22.25
RadNet (RDNT) United States $4.314B 273.81
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.064B 22.67
LifeStance Health (LFST) United States $1.839B 0.00
Astrana Health (ASTH) United States $1.436B 35.57
U.S Physical Therapy (USPH) United States $1.159B 29.91
Pennant (PNTG) United States $0.890B 32.67
Aveanna Healthcare Holdings (AVAH) United States $0.825B 47.00
Atai Life Sciences (ATAI) Germany $0.547B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.002B 0.00